The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Tuberculosis in London: the importance of homelessness, problem drug use and prison
Open accessAbstract
BACKGROUND: The control of tuberculosis (TB) is founded on early case detection and complete treatment of disease. In the UK, TB is concentrated in subgroups of the population in large urban centres. The impact of homelessness, imprisonment and problem drug use on TB control in London is reviewed. METHODS: A cohort study was undertaken of all patients with TB in Greater London to determine the point prevalence of disease in different groups and to examine risk factors for smear positivity, drug resistance, treatment adherence, loss to follow-up and use of directly observed therapy (DOT). RESULTS: Data were collected on 97% (1941/1995) of eligible patients. The overall prevalence of TB was 27 per 100,000. An extremely high prevalence of TB was seen in homeless people (788/100,000), problem drug users (354/100,000) and prisoners (208/100,000). Multivariate analysis showed that problem drug use was associated with smear positive disease (OR 2.2, p<0.001), being part of a known outbreak of drug resistant TB (OR 3.5, p = 0.001) and loss to follow-up (OR 2.7, p<0.001). Imprisonment was associated with being part of the outbreak (OR 10.3, p<0.001) and poor adherence (OR 3.9, p<0.001). Homelessness was associated with infectious TB (OR 1.6, p = 0.05), multidrug resistance (OR 2.1, p = 0.03), poor adherence (OR 2.5, p<0.001) and loss to follow-up (OR 3.8, p<0.001). In London, homeless people, prisoners and problem drug users collectively comprise 17% of TB cases, 44% of smear positive drug resistant cases, 38% of poorly compliant cases and 44% of cases lost to follow-up. 15% of these patients start treatment on DOT but 46% end up on DOT. CONCLUSIONS: High levels of infectious and drug resistant disease, poor adherence and loss to follow-up care indicate that TB is not effectively controlled among homeless people, prisoners and problem drug users in London.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonadherence in Tuberculosis treatment: Predictors and Consequences in New York City
Pablos-Méndez, M., Knirsch, M., Barr, M., Lerner, M., & Frieden, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00402-0 · Cited by 256
Cited by
Fazel, S., & Baillargeon, J. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61053-7 · Cited by 1,080
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
Towards tuberculosis elimination: an action framework for low-incidence countries
Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., Douglas, P., Falzon, D., Gaudreau, M.-A., Goletti, D., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00214014 · Cited by 778
Self-citationRehm, J., Samokhvalov, A. V., Neuman, M. G., Room, R., Parry, C., Lönnroth, K., Patra, J., Poznyak, V., & Popova, S. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-450 · Cited by 458
Tuberculosis, social determinants and co-morbidities (including HIV)
Duarte, R., Lönnroth, K., Carvalho, C., Lima, F., Carvalho, A. C. C., Muñoz-Torrico, M., & Centis, R. (2018) · Pulmonology · doi:10.1016/j.rppnen.2017.11.003 · Cited by 324
Jenkins, H. E., Tolman, A. W., Yuen, C. M., Parr, J. B., Keshavjee, S., Pérez-Vélez, C. M., Pagano, M., Becerra, M. C., & Cohen, T. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60195-1 · Cited by 314
Tuberculosis contact investigation in low prevalence countries: a European consensus
Erkens, C. G. M., Kamphorst, M., Abubakar, I., Bothamley, G. H., Chemtob, D., Haas, W., Migliori, G. B., Rieder, H. L., Zellweger, J.-P., & Lange, C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00201609 · Cited by 272
Craig, G. M., Daftary, A., Engel, N., O’Driscoll, S., & Ioannaki, A. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.011 · Cited by 271
Tabuchi, T., Takatorige, T., Hirayama, Y., Nakata, N., Harihara, S., Shimouchi, A., Fujita, K., Yoshida, H., Tamura, Y., Nagai, T., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-22 · Cited by 38
“showed the high prevalence of 788 per 100,000 among homeless people in 2003 [24].”
BackgroundSmoked drug use in patients with TB is associated with higher bacterial burden
Myers, B., Carney, T., Rooney, J., Malatesta, S., Ragan, E. J., White, L. F., Natcheva, H., Bouton, T. C., Weber, S. E., Farhat, M., et al. (2023) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.22.0650 · Cited by 14
Metadata
- Authors
- Story, A., Murad, S., Roberts, W., Verheyen, M., Hayward, A. C., & for the London Tuberculosis Nurses Network
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2007-08-01
- Volume
- 62
- Issue
- 8
- Pages
- 667-671
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2114800913
- Cited by
- 226
- References
- 1
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.